Acute limb ischemia in COVID-19 patients: an overview

COVID-19 causes a wide range of clinical symptoms. hematologic and cardiovascular involvement induces thromboembolic symptoms in various organs, most notably venous thromboembolism (VTE); peripheral arterial is uncommon. Acute limb ischemia (ALI) vascular emergency known as dramatic drop perfusion that poses challenge to the limb's viability. Given routine need for thromboprophylaxis, hospitalised patients are at an elevated risk ALI, loss, or even mortality. Understanding specific patients, especially extrapulmonary manifests, crucial both better patient care development adequate infection prevention methods. Although ALI complication hospitalized it now being understood can arise with mild symptoms, be first presenting sign absence respiratory It recommended acutely admitted cases should given pharmacologic thromboprophylaxis low molecular weight heparin (LMWH) fondaparinux unless there chance bleeding contraindicated. Anticoagulant treatment, primarily LMWH, correlates strongly improved prognosis serious who follow sepsis-induced coagulopathy requirements have significantly D-dimer levels.